Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Boehringer Ingelheim

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Boehringer Ingelheim's 2013 sales performance.

Boehringer Ingelheim GmbH

First Humira biosimilars reach EU market

First Humira biosimilars reach EU market

Meanwhile, a fifth biosimilar called Cyltezo from Boehringer Ingelheim has been approved for sale but its launch has been held up by patent litigation with AbbVie, according to a Financial Times

The case for a second Brexit referendum: “We need the informed consent of the people”

The case for a second Brexit referendum: “We need the informed consent of the people” Not particularly, ”he says. “There is a pharmaceutical company on my patch, Boehringer Ingelheim, so I am aware of the broader concerns within the industry around the supply chain and taking

Chinese biotech’s global ambitions

Chinese biotech’s global ambitions BeiGene says it as headed off any such concens by working with well-established pharma company and contract manufacturer Boehringer Ingelheim to manufacture its drug.

China’s Innovent to start US trials of anti-CD47 cancer drug

China’s Innovent to start US trials of anti-CD47 cancer drug And earlier this year Boehringer Ingelheim licensed a drug from French biotech OSE Immunotherapeutics that targets SIRP-alpha – which binds to CD47 – in a 1.1bn deal.

Result pages: 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 ()

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cello Health Insight

Cello Health Insight is the global market research arm of Cello Health. With 35 years’ sector experience, we specialise in...

Latest intelligence

patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Paris
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe’s leading hub for life sciences innovation...

Infographics